New research led by Stanford University has developed tools that could significantly enhance the understanding of brain waves and their association with diseases such as epilepsy and Alzheimer’s. The study, published in the journal Cell, highlights the potential for advancements in neuroscience and artificial intelligence.
The research team, headed by Mark J. Schnitzer, professor of biology and applied physics at Stanford’s School of Humanities and Sciences, has introduced technology that uses optical instruments to detect genetically engineered proteins called “voltage indicators.” These indicators reveal neuronal brain wave activity in mice, offering a clearer view than traditional electrodes.
“We’re getting a very broad view of waves propagating across the brain,” said Schnitzer. This new method allows researchers to observe multiple brain areas simultaneously and focus on specific neuron types.
Historically, abnormalities in brain waves have been linked to various diseases including Parkinson’s, Alzheimer’s, epilepsy, and schizophrenia. The challenge has been identifying which neuron types drive these waves. This development aims to address that issue through techniques developed over more than a decade.
In this study, two new TEMPO instruments were used: a highly sensitive fiber optic sensor and an optical mesoscope providing wide images of neural activity. These tools revealed several previously unrecorded waves, including beta waves associated with alertness and theta waves linked to memory processing.
“It seems the brain has an internal clock that synchronizes neural activity,” said Radosław Chrapkiewicz from Schnitzer’s lab. “This could play an important role in further bio-inspired AI models.”
Simon Haziza, lead author and Stanford research scientist, noted the significant applications for neuroscience in understanding brain pathology dynamics. “We are just scratching the surface,” he stated.
Schnitzer also acknowledged contributions from co-authors Vasily Kruzhilin for computational analysis development and Yanping Zhang for mouse model development. Other contributors include researchers from various institutions like New York University and the University of Minnesota.
The study received funding from the National Institutes of Health, with Schnitzer, Chrapkiewicz, and Haziza holding related patents.
